Senti Biosciences is trading 5.76% up at $0.32, alongside a broadly stronger market on September 11, 2026.

  • The S&P 500, Nasdaq Composite, and Dow Jones Industrial Average are each up more than 1%, supporting risk appetite across equities.
  • No fresh company-specific catalyst was identified; CNBC reports no recent news for the security.
  • Recent financing and merger-related announcements remain relevant background but do not clearly explain the session’s move.